background
countryspecif
inform
incid
malaria
travel
provid
reliabl
data
base
pretravel
risk
assess
studi
conduct
among
western
travel
howev
knowledg
report
japanes
travel
method
malaria
case
diagnos
april
decemb
report
nation
infecti
diseas
surveil
bodi
use
numer
group
countri
diseas
acquisit
denomin
number
japanes
travel
visit
individu
countri
deriv
recipi
countri
obtain
japanes
organ
result
addit
welldocu
high
risk
subsaharan
countri
studi
show
travel
papua
new
guinea
expos
significantli
high
risk
malaria
asia
myanmar
highest
risk
gener
malaria
incid
rate
among
japanes
travel
lower
previous
report
western
travel
howev
rate
rather
compar
data
obtain
recent
conclus
malaria
incid
data
travel
taken
consider
pretravel
risk
assess
need
constantli
updat
time
limit
data
interpret
inher
variou
studi
methodolog
also
clarifi
v
l
b
l
e
w
w
w
c
e
n
c
e
r
e
c
c
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
h
e
l
h
c
j
u
r
n
l
travel
medicin
infecti
diseas
million
travel
record
signific
proport
travel
visit
area
risk
malaria
yet
previou
studi
shown
protect
malaria
suboptim
japanes
travel
western
countri
chemoprophylaxi
mainstay
malaria
prevent
measur
travel
highrisk
area
howev
high
proport
user
report
advers
drug
event
predomin
neuropsychiatr
advers
event
among
mefloquin
user
benefit
chemoprophylaxi
use
prevent
malaria
need
care
weigh
risk
advers
drug
event
particularli
pertin
travel
japan
mefloquin
drug
licens
malaria
prophylaxi
countryspecif
inform
incid
malaria
travel
provid
reliabl
data
base
pretravel
risk
assess
studi
conduct
among
western
travel
howev
knowledg
report
japanes
travel
malaria
notifi
diseas
japan
sinc
april
infecti
diseas
control
law
report
smearandor
polymeras
chain
reactionconfirm
malaria
case
record
infecti
diseas
surveil
center
nation
institut
infecti
diseas
tokyo
nation
place
birth
detail
resid
document
report
form
howev
main
countri
resid
preced
sever
year
record
purpos
studi
japanes
travel
defin
resid
japan
previou
sever
year
malaria
case
diagnos
april
decemb
includ
singl
countri
could
identifi
sourc
infect
serv
numer
denomin
number
japanes
travel
visit
individu
countri
data
obtain
japan
nation
tourist
organ
jnto
tokyo
japan
jnto
compil
data
tourism
world
tourism
organ
unwto
pacif
asia
travel
associ
pata
nation
tourism
offic
individu
countri
japanes
nation
resid
japan
prior
travel
defin
japanes
travel
recipi
countri
recipi
countri
defin
number
japanes
visitor
arriv
nation
border
except
mali
chad
use
number
arriv
hotel
countri
includ
denomin
data
avail
least
four
year
studi
period
april
countri
data
avail
entir
studi
period
denomin
estim
base
number
travel
year
malaria
incid
rate
calcul
number
malaria
case
per
travel
countri
among
countri
subsaharan
africa
uganda
ghana
mali
malaria
incid
rate
greater
per
travel
see
tabl
rate
nigeria
two
threefold
less
countri
high
rate
note
central
african
republ
chad
howev
one
case
malaria
countri
rate
could
calcul
west
african
countri
burkina
faso
divor
seneg
cameroon
due
lack
denomin
data
although
case
malaria
import
countri
case
respect
lowest
rate
south
africa
kenya
plasmodium
falciparum
malaria
account
major
infect
african
countri
except
ethiopia
infect
split
almost
equal
due
p
falciparum
plasmodium
vivax
incid
rate
asia
much
lower
african
countri
myanmar
highest
rate
follow
india
pakistan
indonesia
yield
highest
number
import
malaria
case
larg
number
travel
countri
incid
rate
low
fewer
malaria
case
import
thailand
higher
volum
travel
indonesia
incid
rate
lower
overal
p
vivax
domin
speci
account
infect
india
indonesia
thailand
myanmar
philippin
respect
oceania
papua
new
guinea
countri
could
analyz
high
incid
rate
found
compar
african
countri
howev
unlik
african
countri
p
vivax
infect
predomin
six
travel
acquir
malaria
solomon
island
two
infect
due
p
falciparum
four
due
p
vivax
howev
denomin
data
countri
incomplet
brazil
latin
american
countri
analyz
reveal
low
incid
rate
compar
mediumrisk
asian
countri
major
case
due
p
vivax
use
differ
methodolog
studi
conduct
establish
malaria
incid
rate
among
travel
variou
nation
two
longitudin
studi
publish
target
return
travel
questionnair
administ
inflight
airport
followup
questionnair
mail
later
advantag
approach
captur
detail
inform
malaria
infect
eg
purpos
durat
travel
chemoprophylaxi
use
data
use
determin
malaria
risk
travel
adjust
durat
exposur
use
chemoprophylaxi
volum
target
popul
howev
limit
malaria
incid
may
partial
base
report
malaria
infect
diagnos
abroad
e
accuraci
uncertain
studi
malaria
risk
assess
use
case
malaria
report
nation
surveil
bodi
denomin
data
deriv
variou
sourc
denomin
deriv
home
countri
other
recipi
countri
data
provid
unwto
studi
british
swedish
studi
estim
travel
volum
specif
countryarea
use
passeng
survey
conduct
intern
airport
telephon
interview
respect
approach
benefit
larger
sampl
size
numer
denomin
data
greater
diagnost
accuraci
malaria
infect
confirm
return
home
howev
ill
occur
abroad
captur
effect
length
stay
may
evalu
due
lack
data
furthermor
incid
rate
could
greatli
influenc
chemoprophylaxi
use
highrisk
group
could
assess
studi
although
differ
studi
methodolog
make
difficult
compar
result
across
variou
studi
rel
infect
risk
destin
countri
area
could
deriv
individu
studi
inform
invalu
make
malaria
chemoprophylaxi
recommend
travel
particularli
true
japanes
travel
countryspecif
data
previous
acquir
assess
risk
malaria
travel
result
support
previou
find
show
travel
visit
subsaharan
countri
high
risk
malaria
especi
travel
west
africa
infect
due
p
falciparum
also
note
countryspecif
rate
gener
lower
obtain
western
travel
rate
japanes
travel
nigeria
ghana
sever
less
british
italian
danish
travel
recent
howev
steffen
et
al
show
decreas
malaria
incid
rate
among
travel
tropic
africa
per
per
month
stay
previous
report
chemoprophylaxi
current
result
rather
compar
new
data
low
incid
rate
kenya
unexpect
far
lower
british
travel
per
compar
per
danish
travel
per
although
similar
rate
report
among
italian
travel
per
may
japanes
travel
tend
visit
safari
park
may
pose
lower
risk
visit
coastal
area
mombassa
fact
visit
game
park
kenya
found
lower
risk
visit
coast
lower
risk
lake
victoria
line
australian
per
us
bar
exact
figur
shown
studi
demonstr
high
incid
rate
among
travel
papua
new
guinea
per
e
compar
subsaharan
africa
british
studi
also
show
high
rate
oceania
per
case
occur
visit
papua
new
guinea
addit
australian
studi
report
even
greater
risk
solomon
island
papua
new
guinea
studi
howev
could
accur
assess
risk
solomon
island
denomin
data
avail
three
studi
year
base
data
estim
travel
visit
countri
studi
period
six
malaria
case
two
p
falciparum
four
p
vivax
infect
report
give
incid
rate
per
travel
found
malaria
case
acquir
papua
new
guinea
due
p
vivax
due
p
falciparum
even
consid
lower
proport
p
falciparum
infect
chemoprophylaxi
may
recommend
travel
region
oceania
long
recommend
travel
subsaharan
africa
travel
countri
asia
brazil
pose
much
lower
risk
malaria
major
case
due
p
vivax
limit
prescrib
malaria
chemoprophylaxi
travel
indian
subcontin
latin
america
propos
european
group
low
incid
malaria
low
risk
travel
acquir
p
falciparum
infect
studi
result
provid
support
recommend
although
previou
studi
shown
among
asian
countri
risk
malaria
high
india
indian
subcontin
studi
show
highest
risk
myanmar
may
previous
document
similar
previou
studi
risk
malaria
thailand
lower
indonesia
asian
countri
attract
enorm
number
tourist
worldwid
studi
result
subject
limit
data
interpret
malaria
case
develop
cure
return
home
captur
length
stay
malariaendem
countri
extent
chemoprophylaxi
use
known
might
influenc
result
nevertheless
data
incid
malaria
travel
invalu
help
defin
risk
chemoprophylaxi
recommend
data
need
constantli
updat
time
studi
clearli
outlin
limit
data
interpret
inher
variou
methodolog
declar
conflict
interest
